These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8583805)

  • 1. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases.
    Schneider PM; Casson AG; Levin B; Garewal HS; Hoelscher AH; Becker K; Dittler HJ; Cleary KR; Troster M; Siewert JR; Roth JA
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):323-31; discussion 331-3. PubMed ID: 8583805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer.
    Casson AG; Manolopoulos B; Troster M; Kerkvliet N; O'Malley F; Inculet R; Finley R; Roth JA
    Am J Surg; 1994 Jan; 167(1):52-7. PubMed ID: 8311140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 mutations in malignant and premalignant Barrett's esophagus.
    Dolan K; Walker SJ; Gosney J; Field JK; Sutton R
    Dis Esophagus; 2003; 16(2):83-9. PubMed ID: 12823203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and adenocarcinoma--a case report.
    Kimura H; Konishi K; Kaji M; Maeda K; Yabushita K; Miwa A
    Hepatogastroenterology; 2001; 48(42):1662-4. PubMed ID: 11813596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 gene mutations are rare in nondysplastic Barrett's esophagus.
    Novotna K; Trkova M; Pazdro A; Smejkal M; Soukupova A; Kodetova D; Smejkal P; Sedlacek Z
    Dig Dis Sci; 2006 Jan; 51(1):110-3. PubMed ID: 16416221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma.
    González MV; Artímez ML; Rodrigo L; López-Larrea C; Menéndez MJ; Alvarez V; Pérez R; Fresno MF; Pérez MJ; Sampedro A; Coto E
    J Clin Pathol; 1997 Mar; 50(3):212-7. PubMed ID: 9155671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma.
    Moore JH; Lesser EJ; Erdody DH; Natale RB; Orringer MB; Beer DG
    Int J Cancer; 1994 Feb; 56(4):487-93. PubMed ID: 7906678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
    Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-mutant clones and field effects in Barrett's esophagus.
    Prevo LJ; Sanchez CA; Galipeau PC; Reid BJ
    Cancer Res; 1999 Oct; 59(19):4784-7. PubMed ID: 10519384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele.
    Chung SM; Kao J; Hyjek E; Chen YT
    Int J Oncol; 2007 Dec; 31(6):1351-5. PubMed ID: 17982662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutations in Barrett's epithelium and esophageal cancer.
    Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA
    Cancer Res; 1991 Aug; 51(16):4495-9. PubMed ID: 1868473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus.
    Hamelin R; Fléjou JF; Muzeau F; Potet F; Laurent-Puig P; Fékété F; Thomas G
    Gastroenterology; 1994 Oct; 107(4):1012-8. PubMed ID: 7523212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia.
    Neshat K; Sanchez CA; Galipeau PC; Blount PL; Levine DS; Joslyn G; Reid BJ
    Gastroenterology; 1994 Jun; 106(6):1589-95. PubMed ID: 8194706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the TP53 gene in Barrett's adenocarcinoma.
    Audrézet MP; Robaszkiewicz M; Mercier B; Nousbaum JB; Hardy E; Bail JP; Volant A; Lozac'h P; Gouérou H; Férec C
    Hum Mutat; 1996; 7(2):109-13. PubMed ID: 8829627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 immunoreactivity in Barrett's metaplasia, dysplasia, and carcinoma.
    Rice TW; Goldblum JR; Falk GW; Tubbs RR; Kirby TJ; Casey G
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1132-7. PubMed ID: 7983883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's esophagus. The significance of p53 in clinical practice.
    Ireland AP; Clark GW; DeMeester TR
    Ann Surg; 1997 Jan; 225(1):17-30. PubMed ID: 8998117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.
    Ramel S; Reid BJ; Sanchez CA; Blount PL; Levine DS; Neshat K; Haggitt RC; Dean PJ; Thor K; Rabinovitch PS
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1220-8. PubMed ID: 1551529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence.
    Hardwick RH; Shepherd NA; Moorghen M; Newcomb PV; Alderson D
    Gut; 1994 Jun; 35(6):764-8. PubMed ID: 8020801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.